BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 18334671)

  • 1. Beyond the increasing complexity of the immunomodulatory HLA-G molecule.
    Carosella ED; Favier B; Rouas-Freiss N; Moreau P; Lemaoult J
    Blood; 2008 May; 111(10):4862-70. PubMed ID: 18334671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft.
    Moreau P; Paul P; Rouas-Freiss N; Kirszenbaum M; Dausset J; Carosella ED
    Am J Reprod Immunol; 1998 Sep; 40(3):136-44. PubMed ID: 9764357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-G: on the track of immunological functions.
    Le Bouteiller P
    Eur J Immunogenet; 1997 Oct; 24(5):397-408. PubMed ID: 9442807
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA-G expression in hematologic malignancies.
    Yan WH
    Expert Rev Hematol; 2010 Feb; 3(1):67-80. PubMed ID: 21082935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-G molecule.
    Kamishikiryo J; Maenaka K
    Curr Pharm Des; 2009; 15(28):3318-24. PubMed ID: 19860681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-G in organ transplantation: towards clinical applications.
    Deschaseaux F; Delgado D; Pistoia V; Giuliani M; Morandi F; Durrbach A
    Cell Mol Life Sci; 2011 Feb; 68(3):397-404. PubMed ID: 21103908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
    Rajagopalan S; Long EO
    J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-G expression in cancers: potential role in diagnosis, prognosis and therapy.
    Yan WH
    Endocr Metab Immune Disord Drug Targets; 2011 Mar; 11(1):76-89. PubMed ID: 21348818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-G and immune tolerance in pregnancy.
    Hunt JS; Petroff MG; McIntire RH; Ober C
    FASEB J; 2005 May; 19(7):681-93. PubMed ID: 15857883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-G: a tolerance molecule from the major histocompatibility complex.
    Carosella ED; Rouas-Freiss N; Paul P; Dausset J
    Immunol Today; 1999 Feb; 20(2):60-2. PubMed ID: 10098322
    [No Abstract]   [Full Text] [Related]  

  • 11. [HLA-G: an immunoregulatory non classical class I HLA molecule].
    Ksouri H; Bardi R; Mellouli F; Bejaoui M
    Arch Inst Pasteur Tunis; 2009; 86(1-4):27-38. PubMed ID: 20707218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d).
    Shiroishi M; Kuroki K; Rasubala L; Tsumoto K; Kumagai I; Kurimoto E; Kato K; Kohda D; Maenaka K
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16412-7. PubMed ID: 17056715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigen-G: immunotolerant major histocompatibility complex molecule in transplantation.
    Khalil-Daher I; Rouas-Freiss N; Carosella ED; Dausset JB
    World J Surg; 2000 Jul; 24(7):819-22. PubMed ID: 10833249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid production of human KIR2DL4 extracellular domain and verification of its interaction with HLA-G.
    Yu YR; Tian XH; Wang Y; Feng MF
    Biochemistry (Mosc); 2006; 71 Suppl 1():S60-4, 4-5. PubMed ID: 16487070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide presentation and NK inhibition by HLA-G.
    Münz C; Stevanović S; Rammensee HG
    J Reprod Immunol; 1999 Jul; 43(2):139-55. PubMed ID: 10479050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus.
    Agrawal S; Pandey MK
    J Hematother Stem Cell Res; 2003 Dec; 12(6):749-56. PubMed ID: 14977483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface.
    Clements CS; Kjer-Nielsen L; Kostenko L; Hoare HL; Dunstone MA; Moses E; Freed K; Brooks AG; Rossjohn J; McCluskey J
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3360-5. PubMed ID: 15718280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17.
    Agaugué S; Carosella ED; Rouas-Freiss N
    Blood; 2011 Jun; 117(26):7021-31. PubMed ID: 21482709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-G mediates protection from natural killer cytolysis: implications in immune tolerance.
    Carosella ED; Khalil-Daher I; Dausset J; Rouas-Freiss N
    Transplant Proc; 1999; 31(1-2):1192-3. PubMed ID: 10083531
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of HLA-G in immunity and hematopoiesis.
    Carosella ED; Gregori S; Rouas-Freiss N; LeMaoult J; Menier C; Favier B
    Cell Mol Life Sci; 2011 Feb; 68(3):353-68. PubMed ID: 21116680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.